



Mohamed M. Ghoneim1* and Michael W. O’Hara2
Abstract
Background: The interaction of depression and anesthesia and surgery may result in significant increases in
morbidity and mortality of patients. Major depressive disorder is a frequent complication of surgery, which may
lead to further morbidity and mortality.
Literature search: Several electronic data bases, including PubMed, were searched pairing “depression” with
surgery, postoperative complications, postoperative cognitive impairment, cognition disorder, intensive care unit,
mild cognitive impairment and Alzheimer’s disease.
Review of the literature: The suppression of the immune system in depressive disorders may expose the patients
to increased rates of postoperative infections and increased mortality from cancer. Depression is commonly
associated with cognitive impairment, which may be exacerbated postoperatively. There is evidence that acute
postoperative pain causes depression and depression lowers the threshold for pain. Depression is also a strong
predictor and correlate of chronic post-surgical pain. Many studies have identified depression as an independent
risk factor for development of postoperative delirium, which may be a cause for a long and incomplete recovery
after surgery. Depression is also frequent in intensive care unit patients and is associated with a lower health-related
quality of life and increased mortality. Depression and anxiety have been widely reported soon after coronary artery
bypass surgery and remain evident one year after surgery. They may increase the likelihood for new coronary artery
events, further hospitalizations and increased mortality. Morbidly obese patients who undergo bariatric surgery have
an increased risk of depression. Postoperative depression may also be associated with less weight loss at one year
and longer. The extent of preoperative depression in patients scheduled for lumbar discectomy is a predictor of
functional outcome and patient’s dissatisfaction, especially after revision surgery. General postoperative mortality is
increased.
Conclusions: Depression is a frequent cause of morbidity in surgery patients suffering from a wide range of
conditions. Depression may be identified through the use of Patient Health Questionnaire-9 or similar instruments.
Counseling interventions may be useful in ameliorating depression, but should be subject to clinical trials.
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Background
Virtually no one escapes having a condition for which
effective treatment requires anesthesia and surgery [1].
Around 15 % of patients who undergo surgery are at
high risk of complications, leading to 80 % of all peri-
operative deaths. Those who survive suffer a substantial
reduction in functional independence and long-term
survival [2]. Therefore, precise evaluation of each
patient’s risk is important to allow informed decision
making by the patient prior to surgery and target spe-
cific interventions which may improve the outcome.
Major depressive disorder (MDD) or depression is a
heterogeneous disease characterized by low mood, loss
of interest and pleasure in normally enjoyable activities,
loss of energy, difficulties in thinking and decision-
making, appetite and sleep disturbances, psychomotor
disturbances and suicidal ideation [3]. Anxiety is a fre-
quently co-morbid [4]. In high income countries the
average lifetime prevalence is approximately 15 % [5].
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The World Health Organization (WHO) ranks MDD as
the fourth leading cause of disability worldwide and pro-
jects that by 2030, it will be the second leading cause
[6]. MDD represents a serious and often recurrent dis-
order. In addition to reduced general functioning and
quality of life, depressed patients suffer from increased
physical morbidity and mortality [7, 8]. The aetiology of
the disease is not well understood, and the rates of its
diagnostic recognition are poor (35–45 %) [9]. Further-
more, only a minority of diagnosed patients are provided
with adequate treatment. Ormel, et al. [10] found that in
high-income countries severely disabling mental disor-
ders are only half as likely to be treated compared to ser-
ious disabling physical disorders.
Literature search
Literature search was conducted in the following elec-
tronic databases: PubMed, CINAHL, Cochrane Library,
PsycNet, Scopus, Web of Knowledge and NCBI. The fol-
lowing search terms were used: depression and surgery,
depression and postoperative complications, depression
and postoperative cognitive impairment, depression and
cognition disorder, depression and intensive care unit,
depression and mild cognitive impairment, and depres-
sion and Alzheimer’s disease. The search was started in
June, 2012 down to 1982. We updated the search from
June 2012 to April 2014 in Pub Med only. Articles in
English language were the only ones pursued. Despite a
sizable amount of literature that was examined, we did
not run across a single comprehensive review of the
interactions of depression with surgery as opposed to in-
teractions with single types of surgeries, e.g., cardiac,
bariatric, etc.
In this review we discuss the effects of depression on
immunity, cognition and acute and chronic postopera-
tive pain. We follow with discussion on the incidence of
postoperative delirium and in patients being cared for in
intensive care units. Then we discuss the interaction of
depression with some specific surgeries. We conclude
with recommendations for management of the depressed
patient and future research.
Review of the literature
Immunity, depression and surgery
The immune system helps to protect the body against
disease, toxic agents, stress and injury. Psychological
stress in humans induces an inflammatory response
through the production of small messenger molecules,
pro-inflammatory cytokines such as interleukin 1beta
(IL-1β), interleukin 6 (IL-6) and tumor necrosis factor
alpha (TNFα). All of these are released by macro-
phages, other peripheral immune cells and microglia, as
part of the early acute phase reaction to combat insult or
threat [11, 12]. The state of immune depression is
characterized by a depression in T-cell function and a shift
toward a TH2 T-cell phenotype [13].
The immune mechanisms involved in the patho-
physiological processes include networks between endo-
crine, autonomic (the hypothalamic-pituitary-adrenal
axis) and neurotransmitter systems [14]. Bufalino, et al.
[15], reviewed recently the existing literature on the gen-
etic variants within key elements of the inflammatory
system and the risk of depression. There was evidence
for the involvement of genes related to inflammatory cy-
tokines and enzymes (COX-2 and PLA2) in the aetiology
of depression. In addition, single nucleotide polymor-
phisms (SNPs) in genes related to the serotonin pathway
may play a fundamental role in the shared genetic liabil-
ity to both depressive symptoms and immune activation.
Decreased immunity may increase the risk of postopera-
tive infections and cancer growth in patients harboring
malignant tumors.
Surgery and postoperative infections
Tissue injury following surgery results in depressed
immunity leading to an increased risk of infectious com-
plications. Postoperative infections are major causes of
increased morbidity, mortality and cost [16]. Several
studies reported increased rate of postoperative infec-
tions in patients suffering from depression, e.g., after
coronary artery bypass surgery (CABG) [17], total knee
arthroplasty [18], craniotomies [19], insertion of ven-
tricular assist devices [20]. The latter is of particular
serious consequences.
Immunity and malignancy
Immunity also plays an important role in cancer devel-
opment, growth and progression. In the setting of hu-
man cancer, myeloid-derived suppressor cells (MDSCs)
increase in the body including the tumor site [21].
MDSCs and tumor cells form a feedback loop that pro-
motes tumor growth and progression [22]. MDSC re-
lease factors that inhibit immunity by blocking T-cell
and NK-cell (types of lymphocytes) effector functions,
attenuate T-cell migration and enhance angiogenesis,
ultimately, promoting tumor growth and progression
[23, 24].
Although some human studies [25] suggest that pa-
tients with depression may be at a higher risk for devel-
oping cancer, a larger number of studies [26, 27] suggest
that it is unlikely that depression is an independent risk
factor for cancer. Some studies reported high prevalence
of depression in patients with malignancies [28, 29],
while others found the rates of major depression to be
similar to those of patients in primary care [30]. This
does not contradict the fact that depressive symptoms
are commonly experienced by most people in response
to sad or stressful life events such as their diagnoses
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with cancer and its often aggressive and debilitating
treatments.
In addition to depression affecting the quality of life
[31], the mortality of the cancer patient is increased [29,
32]. The causes may be biological, e.g., genetic predis-
position, decreased immunity and/or psychosocial. De-
pressed patients are more likely to smoke [33, 34], or to
be alcohol dependent [35] and to be non-compliant with
treatments. Spiegel, et al. [36], studied the effect of psy-
chosocial treatment on survival of patients with meta-
static breast cancer. One group was randomized to
receive group psychotherapy and the other served as a
control. After 20 months, patients in the study group
lived one and a half year more than those in the control
group. La Raja, et al. [37], compared patients who had
undergone surgery for breast carcinoma followed by psy-
chotherapy and a control group. After 1 year 94 % of the
patients were free of malignancy, compared to 80 % in
the control group. More studies in this area are needed.
Depression and postoperative cognitive impairment
Depressive symptoms flag an increased and robust likeli-
hood of cognitive decline and conversely, cognition at
baseline is related to the course of depressive symptoms.
The cognitive impairment typically consists of episodic
memory impairment, poor attention, decrement of
visuospatial skills, information processing and executive
dysfunction [38, 39]. As a result, depression may have a
major adverse effect on every day functioning. Depres-
sion is also a strong risk factor for normal subjects pro-
gressing to mild cognitive impairment (MCI) [40]. The
construct of MCI identifies the intermediate state of
cognitive function between the changes seen in aging
and those fulfilling the criteria for dementia of Alzhei-
mer’s disease (AD) [41]. The occurrence of depressive
symptoms also constitute a predictor for patients who
are more likely to progress to Alzheimer’s dementia [42].
The syndrome, postoperative cognitive impairment
(POCD), is a relatively serious complication of
anesthesia and major surgery for elderly patients over
60 years of age. An early cognitive decline in the first
week post-surgery of about 30–50 % of patients is
followed by a persistent decline in 10–20 % at 3 months
postoperatively. It leads to problems with learning,
memory, attention and concentration which may affect
performance of daily activities and may result in early
retirement and resignation from work [43]. Factors re-
lated to vascular disease are important for both POCD
and depression [43, 44].
As depression commonly leads to cognitive impair-
ment, one may expect that depression should be
accounted for in all studies of POCD, however, a recent
review of the literature [43] shows otherwise. In the ab-
sence of a controlled and randomized study design, it is
reasonable to recommend the measurement of depres-
sion in POCD trials.
Pain and depression
Pain has been viewed as a multidimensional experience
with sensory, motivational and affective components
[45]. There is the experience of the sensory component
which includes the perception of location, quality and
intensity of the noxious stimulus and the emotional di-
mension which processes the affective salience or un-
pleasantness of the stimulus. When pain and depression
occur together, they result in worsening of both condi-
tions [46].
Acute postoperative pain
Many patients suffer from moderate to severe postoper-
ative pain despite recent improvements in pain treat-
ment. Severe pain is associated with decreased patient
satisfaction, delayed postoperative ambulation, the devel-
opment of chronic postoperative pain, increased inci-
dence of pulmonary and cardiac complications, and
increased morbidity and mortality [47, 48]. Relatively
few studies have investigated the relationship between
acute postoperative pain and psychological morbidity.
Taenzer, et al. [49] found that depression prior to sur-
gery was significantly correlated with postoperative pain
measurements and analgesic requirements. De Cosmo,
et al. [50] found that patients with preoperative anxiety
and depression had higher pain intensities postopera-
tively and larger consumption of tramadol.
It is possible also that adequate postoperative analgesia
may play a part in protection against postoperative de-
pression. Royse, et al. [51] investigated the effects of high
thoracic epidural analgesia versus a patient controlled
intravenous analgesia for 3 days in patients following
coronary artery bypass surgery (CABG). High thoracic
epidural analgesia, which provides excellent pain relief
to the majority of patients, resulted in a lower risk of de-
pression for 6 months or more following surgery com-
pared to patients who received patient controlled
intravenous analgesia which provides a much greater
variability for pain relief [52].
Chronic post-operative pain
Chronic postsurgical pain (CPSP) is a serious clinical
problem [53]. It is a common reason for early retirement
and unemployment and represents an extensive drain on
societies' resources [54, 55].
The factors that seem to affect its incidence include
the extent of preoperative pain, trauma during surgery
and anxiety and depression [56, 57]. Cancer patients
seem particularly susceptible [58]. Depression affects
30–100 % of patients with chronic pain [53].
Hinrichs-Rocker, et al. [59] systematically reviewed
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the psychosocial predictors and correlates for chronic
post-surgical pain. Depression was a strong predictor.
Adogwa, et al. [60] and Chaichana, et al. [61] came
to the same conclusion. Comorbidity of pain and de-
pression provokes worsening of both conditions [62].
Chronic pain is difficult to treat. It is important
therefore to identify patients at high risk for its devel-
opment and optimize their management.
Mechanisms linking pain and depression
Pain has been shown to cause altered synaptic connect-
ivity at the prefrontal cortex [63] and hippocampus [64],
as well as altered dopamine signaling from the ventral
tegmental area [65]. These changes have been known to
trigger negative symptoms of depression and may form
the link between pain and depression [66]. More re-
cently, dysfunction in the serotonergic (5HT) system has
been suggested to plan an important role in the patho-
physiology of both conditions. Lebe, et al. [67], demon-
strated that pain after lumbar disc surgery modulates the
association between 5HT gene polymorphisms and de-
pression [67].
Postoperative delirium and depression
Postoperative delirium is a clinical syndrome character-
ized simply by an acute change in mental status with a
fluctuating course, a prominent disturbance in attention,
and either disordered thinking or altered level of con-
sciousness. It occurs in 15–53 % of surgical patients over
the age of 65 years [68] and is associated with significant
morbidity and mortality [69]. Although the pathophysi-
ology of the relationship between the two conditions re-
mains to be clarified, many studies have identified
depression as an independent risk factor for postopera-
tive delirium [70, 71]. Patients with preoperative depres-
sive symptoms are more likely to develop postoperative
delirium of a longer duration [72] and incomplete recov-
ery to independent functioning after surgery [73].
Depression and the intensive care patient
The introduction of intensive care units to manage pa-
tients who are critically ill after surgery led to their
increased survival. However, some of the survivors may
suffer from cognitive disabilities and other psychiatric
disorders. Rincon, et al. [74] found a 13.7 % incidence of
depression on the first day of admission to the ICU. Lib-
erzon, et al. [75] demonstrated a 32 % incidence of de-
pression or PTSD in patients who were admitted to the
unit after abdominal aortic surgery. Sukantrat, et al. [76]
reported 35 % and 47 % incidence of depression at 3 and
9 months respectively after discharge from the unit.
Davydow, et al. [77] conducted a review of depression
in general intensive care unit (ICU) survivors. From 14
studies, the median point prevalence of “clinically
significant” depressive symptoms was 28 %. Early post-
ICU depressive symptoms were a strong risk factor for
subsequent depressive symptoms and were associated
with lower quality of life. Future studies should investi-
gate the factors linking individual patients, critical illness
and post-ICU recovery with depression. Myhren, et al.
[78] studied 194 patients after their discharge from ICU.
Optimism was a strong predictor for less anxiety and de-
pression symptoms; while pessimism had the opposite
effect. Intervention by clinical psychologists when
needed during the ICU stay promotes patients’ recover-
ies from depression and other psychiatric complications
[79].
Depression is common in patients with diabetes and
increases the rate of complications from this disease
[80]. Diabetic patients with two or more complications,
especially neuropathy or nephropathy are at high risk of
depression [81]. This knowledge can help clinicians to
identify patients at risk of depression and facilitate early
treatment. Patients with diabetes and comorbid depres-
sion have a greater risk of ICU admission. Davydow, et
al. [82] suggested that improving depression treatment
in patients with diabetes could potentially prevent
hospitalization for critical illnesses and lower healthcare
costs. Depression and anxiety preceding myocardial in-
farction were associated with increased incidence of car-
diac complications in coronary care units and ICUs,
following infarction [83]. Identification and treatment of
depression may prevent these complications. Cerebral
stroke is another cause for admission to ICU. Post-
stroke depression is a very frequent complication with
an estimated prevalence of as high as 80 % and with in-
creased risk of mortality [84].
Influence of depression on surgical mortality
In addition to increased rate of mortality in surgical
patients with depression who were also suffering from
heart disease [85, 86], malignancy [26, 87] or other
specific causes [18], Abrams, et al. [88] investigated
surgical patients admitted to ICUs. Anxiety and de-
pression increased the risk of death. Cuijpers, et al.
[89] also reported an increased risk of all causes of
mortality in a meta-analysis of community studies.
Several causes for the increased mortality have been
suggested. One is non-compliance of depressed pa-
tients with medical recommendations [90, 91]. It has
also been suggested that patients with existing psychi-
atric morbidity may be more likely to undergo sur-
gery by a lower-quality surgeon [92]. Another factor
is the tendency of depressed patients to lead a less
than healthy lifestyle, e.g. tobacco smoking and exces-
sive alcohol consumption [93]. Depressed patients
may seek advice at a later stage of illness, lack effect-
ive communications with physicians and the delays
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resulting from treatment of depression before surgery
[88].
Depression has a strong association with suicide. The
probability of attempted or successful suicide in depres-
sive people is much higher than for the general popula-
tion [94, 95]. Bariatric surgery patients in particular have
a higher suicide rate than the general population. Tindle,
et al. [96] reported a completed suicide rate of 13.7 per
10,000 for male patients and 5.2 per 10,000 for female
patients, compared to 2.4 and 0.7 respectively in the
general U.S. population. Peterhänsel, et al. [94] reviewed
the results of thirty studies concerning bariatric surgery
and completed suicide. They estimated a suicide rate of
4.1/10,000 person-years, higher than the general popula-
tion. As will be reported later when discussing bariatric
surgery, obesity has a strong association with depression.
Although for many patients their depression symptoms
improve following surgery, they remain an issue for
some patients.
Depression and some specific surgeries
Patients who undergo different surgical procedures
probably have different pathophysiologies which may
affect their postoperative course. We chose three surger-
ies that have been adequately studied in their relation to
depression namely, CABG, bariatric surgery and spine
surgery.
Depression and CABG
For some patients with coronary artery disease, despite
successful surgery, the outcome can be disappointing,
because of psychological impairments. The prevalence of
depression approximates between 30 % and 40 % and it
increases the risk of morbidity and mortality. It increases
the incidence of postoperative delirium, unplanned hos-
pital admissions and cardiac events, e.g., arrhythmias, re-
turn of angina symptoms [97, 98]. Doering, et al. [17,
73] studied patients at discharge from the hospital and
6 weeks later. Depressive symptoms were associated with
infections, impaired wound healing, poor emotional and
physical recovery, and impaired quality of life.
One consistent feature of the papers reviewed was the
recommendation that clinicians ought to routinely assess
patients’ depressive and anxiety symptoms prior to sur-
gery which also conforms with the recommendation by
the American Heart Association [99]. Future random-
ized and controlled studies are needed to confirm the
value of these recommendations.
Bariatric surgery and depression
Extreme obesity, characterized by a body mass index
(BMI) of 40 kg/m2 or greater, is associated with signifi-
cantly increased mortality, principally from cardiovascu-
lar disease, type 2 diabetes and several cancers [100]. It
is also associated with increased risk of depression [101].
Surgically induced weight loss is a valid treatment.
Depression in bariatric surgery candidates
Methodologic limitations, including the absence of well-
defined control groups, the absence of randomization
and the use of suboptimal psychometric measures [102],
prevent definitive interpretation of the rates of psycho-
pathology observed in bariatric surgery candidates.
Questionnaires which assess self-report symptoms may
be often biased by confounding covariates as compared
to symptoms confirmed by an interview [103]. An epi-
demiological study of nearly 40,000 individuals found
that persons who had a BMI of 40 kg/m2 or higher were
nearly five times more likely to have experienced an epi-
sode of major depression in the past year than were indi-
viduals of average weight [104]. This and other findings
strongly suggest that extremely obese individuals are
more vulnerable to depression, although the factors
responsible for this susceptibility are not clear. Weight
related stigmatization and the emotional distress associ-
ated with the medical complications of morbid obesity
may be contributors [105, 106]. Therefore, candidates
for bariatric surgery should be assessed for depression
and those in need should be treated.
Changes after bariatric surgery
Most studies reported a significant decrease in depres-
sion and anxiety rating scores and improvement in
quality of life scores after surgery. And there is usually a
positive association between the decrease in the
depression and anxiety scores and the amount of weight
loss [107]. Deactivation of inflammatory pathways,
normalization of HPA axis functioning, and reduction of
psychological distress due to weight loss might be the
explanation. Postoperative depression was associated
with less weight loss at the 24–36 month follow-up as-
sessment [103].
Some patients may regain some of the weight they had
lost, usually within 2–4 years. The follow-up data of the
Swedish Obese Subjects study [107, 108] showed that
the depression scores increased again over time after a
strong initial improvement. Importantly, greater weight
loss was significantly associated with greater reduction
of depressive symptoms in the long term. Close surveil-
lance of patients might help to identify those who would
benefit from interactions that target depression as a po-
tential mediator for poorer weight loss outcome. It may
also identify patients who harbor suicidal ideation.
Depression and spine surgery
Lumbar discectomy is the most common surgical pro-
cedure for patients experiencing back and leg pain from
herniated lumbar discs. However, not all patients will
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benefit; some will be vulnerable to poor clinical outcome
[61], especially with revision surgery [60]. Depression
and anxiety are common in many disease states of
chronic pain, as was mentioned before and are potential
predictors of surgical outcomes. Some studies reported
high rates of preoperative depression [109, 110], and
failed back surgery syndrome is a common problem with
enormous costs to patients, insurers and society [111].
Its commonest cause is depression [60], which should be
assessed and treated preoperatively to avoid another
failed operation.
Löbner, et al. [109] in a longitudinal observation study,
identified several factors which increase the risk of de-
pression, e.g., females, older age, lower education level,
etc. Future studies should include a non-surgery control
group of patients together with the surgical cohort in a
randomized fashion to build a consensus for screening
and management of patients for disc surgery.
A framework for counselling interventions in major
surgery patients is detailed in Fig. 1.
Clinical management of depression
Even in a busy surgical practice, it is relatively easy to
screen for depression. There are numerous tools
available that can be administered pre-operatively,
e.g., the Patient Health Questionnaire-9 [112] which
has 9 items that assess the symptoms of major de-
pression,3 each of which are rated on a 4-point (0–3)
scale. A score of 10 or above indicates that the pa-
tient is at high risk for major depression (sensitivity
= .88; specificity = .88). For patients who screen posi-
tive, the next step is to do a more formal evaluation
of the patient’s depression and to develop a treatment
plan if indicated by a psychiatrist or clinical health
psychologist. These types of consultations usually can
occur quickly and should not ordinarily delay surgery.
One major question will be whether the depression
symptoms are largely reflective of the underlying dis-
ease for which the surgery is being performed, e.g.,
hypothyroidism, hyperparathyroidism or whether the
symptoms reflect comorbid depression. For the sur-
geon (and patient) the question is whether to delay
surgery until the patient has at least showed a re-
sponse to the treatment. In cases which cannot be
delayed, pharmacotherapy or cognitive behavior ther-
apy can begin as soon as the patient is sufficiently re-
covered. For purely elective surgeries, the operation
may be delayed until the patient has responded to
treatment.
Unfortunately, it is not always the case that patients
will respond to psychotherapy or medications quickly.
Moreover, some patients will come to surgery with a
long history of failed treatments for depression and will
hold out little likelihood that a new round of depression
treatment will be successful. To complicate matters
more, perioperative use of serotonin reuptake inhibitors
which are used for treatment may contribute to adverse
postoperative outcomes which include death [113]. Fol-
lowing surgery it is recommend that patients should be
screened for depression, particularly those who were
Fig. 1 A framework for counselling interventions in major surgery patients. The numbers refer to answers to key questions as follows: (1) There
are not enough studies comparing surgery with non-surgery cohorts. (2) There are potential adverse effects of treatment and/or its failure (3) and
(4). There is a need for randomized and controlled trials to prove the efficacy of screening and/or treatment of depression before anesthesia and
surgery in reducing postoperative morbidity and mortality.
Ghoneim and O’Hara BMC Surgery  (2016) 16:5 Page 6 of 10
identified as depressed before surgery. Again, referrals to
consultation liaison psychiatry and clinical psychology
can be made in the context of positive screens.
Conclusions
The available literature suggests that depression is
prevalent in patients before major surgery. Non-
alleviated, it may predict increased morbidity and
mortality after the operation. It may be associated
with greater postoperative pain, higher incidence of
postoperative infections, progression of malignant
tumors, poor health-related quality of life as well as
other complications. Accurate prediction of periopera-
tive risk enables informed consent for patients before
surgery, guides clinical decision making in the peri-
operative period and allows clinical audit [114]. Mul-
tiple tools are available [115], but unfortunately, none
of them include major depression among the patient-
related factors.
The evidence base for the detrimental effects of de-
pression in the surgical patient consists mainly of
relatively small studies which make chance findings
more likely and prevent considering all possible con-
tributing factors (Fig. 1). They are mostly single cen-
ter studies and are therefore subject to confounding,
particularly when they are non-blinded which is usu-
ally the case. It is not sufficient simply to demon-
strate that poor clinical outcomes are more frequently
associated with depression. Higher rates of psychiatric
disorders in surgical than in non-surgical patients
would suggest that anesthesia and surgery contribute
to the emergence of psychiatric morbidity. Unfortu-
nately, such studies are uncommon. Large multi-
center randomized controlled trials are needed to
confirm that screening and treatment of depression
improve the outcome of surgery (unless randomization is
deemed ethically improper). Until such studies have been
performed, we must recognize the limitations of our data-
base and make best use of them to reduce the periopera-
tive risk in the patients.
Ultimately the etiology and the molecular nature of
the brain deficits in depression need to be elucidated
and new approaches to reverse them have to be found.
No new antidepressant has been developed in the last
quarter century. In the meantime more work is needed
in the public health arena. A multimodal approach to
perioperative care, and the use of clinical registries may
help to improve the management of the surgical patient
[116]. They provide a nationwide, prospective, observa-
tional database; therefore avoiding performance bias,
which can occur if patients are recruited from selected
surgeons and centers (Table 1). In the future, these ef-
forts may change the potentially high-risk depressed sur-
gical patient to a low or no risk one.
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